PDK1 and benign neoplasm: On the other hand, the lack of PDK1 expression in normal ovaries, its weak expression in benign tumours and its elevated expression in pre-malignant and low- to high-grade ovarian carcinomas provide compelling evidence of its oncogeneic role in ovarian cancer progression.